|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV049530445 |
| 003 |
DE-627 |
| 005 |
20230624154402.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
200518s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.earlhumdev.2019.104931
|2 doi
|
| 028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000927.pica
|
| 035 |
|
|
|a (DE-627)ELV049530445
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(19)30565-1
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Yotani, Nobuyuki
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Withholding and withdrawal of life-sustaining treatments for neonate in Japan: Are hospital practices associated with physicians' beliefs, practices, or perceived barriers?
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a To describe the current status of withholding or withdrawal of life-sustaining interventions (LSI) for neonates in Japan and to identify physician- and institutional-related factors that may affect advance care planning (ACP) practices with parents.
|
| 700 |
1 |
|
|a Nabetani, Makoto
|4 oth
|
| 700 |
1 |
|
|a Feudtner, Chris
|4 oth
|
| 700 |
1 |
|
|a Honda, Junko
|4 oth
|
| 700 |
1 |
|
|a Kizawa, Yoshiyuki
|4 oth
|
| 700 |
1 |
|
|a Iijima, Kazumoto
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:141
|g year:2020
|g pages:0
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2019.104931
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 141
|j 2020
|h 0
|